{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-16T15:57:07.724986+00:00","published_at":"2026-10-16T13:51:24.289996+00:00","section":"evidence","data":{"state":"PUBLISHED","evidence":[{"evidence_id":"alpha:projection-evidence:3689ca642bfc033d173b2bc49bafdfee36e7db450c6b987dfdf226863ed0bae7","aliases":[],"source_type":"canonical_identity","source_family":"open_web","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma","title":"Alpha canonical company public projection","identifier":null,"locator":null,"source_date":null,"retrieved_at":"2026-10-16T13:51:24.289996+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"open_web","score":35,"source_family":"open_web","reasons":["Matched open_web source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:legal_name:1","stance":"supports"},{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:entity_status:3","stance":"supports"},{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:published_fact:5","stance":"supports"},{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:published_fact:6","stance":"supports"},{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:published_fact:7","stance":"supports"},{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:security_listing:53","stance":"supports"}],"claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:legal_name:1","alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:entity_status:3","alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:published_fact:5","alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:published_fact:6","alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:published_fact:7","alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:security_listing:53"]},{"evidence_id":"alpha:projection-evidence:9015985fad92d88e74db5c67c27c419035e65a05002428d7db43c41165fb4d6f","aliases":[],"source_type":"SEC filing","source_family":"sec","publisher":"VERTEX PHARMACEUTICALS INC / MA Form 10-K (filed 2026-02-13)","url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000056/vrtx-20251231.htm","title":"VERTEX PHARMACEUTICALS INC / MA Form 10-K (filed 2026-02-13)","identifier":null,"locator":null,"source_date":null,"retrieved_at":"2026-08-29T22:19:43Z","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:official_website:4","stance":"supports"},{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:published_fact:8","stance":"supports"}],"claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:official_website:4","alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:published_fact:8"]},{"evidence_id":"alpha:projection-evidence:document:4204b33890421295f8e7a46549171c478894d031cbbeaf34c4d37a139f430827","aliases":[],"source_type":"sec_filing","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","title":"Vertex Pharmaceuticals Incorporated director board source","identifier":null,"locator":null,"source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:46.353365+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:9","stance":"supports"}],"claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:9"]},{"evidence_id":"alpha:projection-evidence:document:b9e93410980e0de555ceb4e5a4d7ad206b129a10d48051765eabd6aac39769cc","aliases":[],"source_type":"sec_filing","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","title":"Vertex Pharmaceuticals Incorporated director board source","identifier":null,"locator":null,"source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:46.353365+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:10","stance":"supports"}],"claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:10"]},{"evidence_id":"alpha:projection-evidence:document:56bd4087aac2efb2a4f1ba7b4ec47c52e892e0a1f2b3f43408a98943c5b78b94","aliases":[],"source_type":"sec_filing","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","title":"Vertex Pharmaceuticals Incorporated director board source","identifier":null,"locator":null,"source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:46.353365+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:11","stance":"supports"}],"claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:11"]},{"evidence_id":"alpha:projection-evidence:document:3a71ee491d4edd7ad4c444364a54a6cd98e460c73c0e4a530f213dc158d42163","aliases":[],"source_type":"sec_filing","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","title":"Vertex Pharmaceuticals Incorporated director board source","identifier":null,"locator":null,"source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:44.05354+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:12","stance":"supports"}],"claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:12"]},{"evidence_id":"alpha:projection-evidence:document:f71d7ad63d317a89a9a896279a66a7b5677513bdc42b3aedecfff0ae33710b7f","aliases":[],"source_type":"sec_filing","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","title":"Vertex Pharmaceuticals Incorporated director board source","identifier":null,"locator":null,"source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:44.446969+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:13","stance":"supports"}],"claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:13"]},{"evidence_id":"alpha:projection-evidence:document:c0e47d7c4b33b030ce488922138a8c66f509c7255719adf92e5fa78fc8a4315a","aliases":[],"source_type":"sec_filing","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","title":"Vertex Pharmaceuticals Incorporated director board source","identifier":null,"locator":null,"source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:46.353365+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:14","stance":"supports"}],"claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:14"]},{"evidence_id":"alpha:projection-evidence:document:4488043de931797e682a0536afc312cae15082e3f75b3d0b6fe366f5bb05bca4","aliases":[],"source_type":"sec_filing","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","title":"Vertex Pharmaceuticals Incorporated director board source","identifier":null,"locator":null,"source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:44.446969+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:15","stance":"supports"}],"claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:15"]},{"evidence_id":"alpha:projection-evidence:document:3d9bdbb6429f64e8b2097690ef5c293918cb8bd125d855b9b9f14945d6186a6a","aliases":[],"source_type":"sec_filing","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","title":"Vertex Pharmaceuticals Incorporated director board source","identifier":null,"locator":null,"source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:44.446969+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:16","stance":"supports"}],"claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:16"]},{"evidence_id":"alpha:projection-evidence:document:40fbba593a76c37fecbd172eaa34cbf956f7086dc717081d95a2a6812f5f78ec","aliases":[],"source_type":"sec_filing","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","title":"Vertex Pharmaceuticals Incorporated director board source","identifier":null,"locator":null,"source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:44.446969+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:17","stance":"supports"}],"claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:17"]},{"evidence_id":"alpha:projection-evidence:document:00cf7db9df23d437fa08d5fa748d02f566c1f00005ca782a52b7a6b0fd9dfa87","aliases":[],"source_type":"sec_filing","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","title":"Vertex Pharmaceuticals Incorporated director board source","identifier":null,"locator":null,"source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:46.353365+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:18","stance":"supports"}],"claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:18"]},{"evidence_id":"alpha:projection-evidence:document:65aa0f473458ddc2d4211d222c40e747b4e05982619bf8cfdbf0acff95ada785","aliases":[],"source_type":"sec_filing","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","title":"Vertex Pharmaceuticals Incorporated director board source","identifier":null,"locator":null,"source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:44.446969+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:19","stance":"supports"}],"claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:19"]},{"evidence_id":"alpha:projection-evidence:document:643565076b28be530e27bc7c6bb3b8e5c4f9d2ef18b6ed3c3477341241fc6f2d","aliases":[],"source_type":"sec_filing","source_family":"unknown","publisher":null,"url":null,"title":"VRTX executive roster source","identifier":null,"locator":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:15.745913+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"unknown","score":20,"source_family":"unknown","reasons":["No governed source-family rule matched."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:20","stance":"supports"}],"claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:20"]},{"evidence_id":"alpha:projection-evidence:document:10073b8c8eebe93a66db157b64687d2d3997bc19eb9044ee3696d363709c8ca8","aliases":[],"source_type":"sec_filing","source_family":"unknown","publisher":null,"url":null,"title":"VRTX executive roster source","identifier":null,"locator":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:25.419065+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"unknown","score":20,"source_family":"unknown","reasons":["No governed source-family rule matched."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:21","stance":"supports"}],"claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:21"]},{"evidence_id":"alpha:projection-evidence:document:bcba2bd490d216b470f7f5bfee08ab970104433bf97d57f0ffbc8c0646e2f879","aliases":[],"source_type":"sec_filing","source_family":"unknown","publisher":null,"url":null,"title":"VRTX executive roster source","identifier":null,"locator":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:15.433956+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"unknown","score":20,"source_family":"unknown","reasons":["No governed source-family rule matched."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:22","stance":"supports"}],"claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:22"]},{"evidence_id":"alpha:projection-evidence:document:ecb260e2fc826c6ce0d9dc519493846b3dad9f6e6755e4e91fe7588cfad341c0","aliases":[],"source_type":"sec_filing","source_family":"unknown","publisher":null,"url":null,"title":"VRTX executive roster source","identifier":null,"locator":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:15.745913+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"unknown","score":20,"source_family":"unknown","reasons":["No governed source-family rule matched."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:23","stance":"supports"}],"claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:23"]},{"evidence_id":"alpha:projection-evidence:document:d6d906836dc60a9cb04c04a972bfe36d39683fb549b84171d05c66770d06294e","aliases":[],"source_type":"sec_filing","source_family":"unknown","publisher":null,"url":null,"title":"VRTX executive roster source","identifier":null,"locator":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:15.433956+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"unknown","score":20,"source_family":"unknown","reasons":["No governed source-family rule matched."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:24","stance":"supports"}],"claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:24"]},{"evidence_id":"alpha:projection-evidence:document:11c9716331af59ab69a0aebe420f77e14312aef120cdd656894afe2d18781f2b","aliases":[],"source_type":"sec_filing","source_family":"unknown","publisher":null,"url":null,"title":"VRTX executive roster source","identifier":null,"locator":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:15.745913+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"unknown","score":20,"source_family":"unknown","reasons":["No governed source-family rule matched."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:25","stance":"supports"}],"claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:25"]},{"evidence_id":"alpha:projection-evidence:document:928c35a8eb10908bfafa795855984082d0cf83fa1beaab5098328b05eb4f4dbe","aliases":[],"source_type":"sec_filing","source_family":"unknown","publisher":null,"url":null,"title":"VRTX executive roster source","identifier":null,"locator":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:15.433956+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"unknown","score":20,"source_family":"unknown","reasons":["No governed source-family rule matched."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:26","stance":"supports"}],"claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:26"]},{"evidence_id":"alpha:projection-evidence:document:a12b804ccfa191b0a98a7bf01680ad0b850214b84d0467db3d7f4efedc2d6e5b","aliases":[],"source_type":"sec_filing","source_family":"unknown","publisher":null,"url":null,"title":"VRTX executive roster source","identifier":null,"locator":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:15.745913+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"unknown","score":20,"source_family":"unknown","reasons":["No governed source-family rule matched."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:27","stance":"supports"}],"claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:27"]},{"evidence_id":"alpha:projection-evidence:document:15a914491ac61cea12830ac4dae1f930b6ac324a037cb07cbd6c3f1bcb573247","aliases":[],"source_type":"sec_filing","source_family":"unknown","publisher":null,"url":null,"title":"VRTX executive roster source","identifier":null,"locator":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:15.745913+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"unknown","score":20,"source_family":"unknown","reasons":["No governed source-family rule matched."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:28","stance":"supports"}],"claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:28"]},{"evidence_id":"alpha:projection-evidence:document:bd8e625c43229cd60017e6c676a3355f568a031ad70b6019bbdfc8ac786e4c03","aliases":[],"source_type":"sec_filing","source_family":"unknown","publisher":null,"url":null,"title":"VRTX executive roster source","identifier":null,"locator":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:25.419065+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"unknown","score":20,"source_family":"unknown","reasons":["No governed source-family rule matched."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:29","stance":"supports"}],"claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:29"]},{"evidence_id":"alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34","aliases":[],"source_type":"sp500-board-director-completeness-remediation-2026-05-15","source_family":"sec","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000153/vrtx-20260402.htm","title":"Audit","identifier":null,"locator":null,"source_date":null,"retrieved_at":null,"content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_record:30","stance":"supports"},{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:31","stance":"supports"},{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:32","stance":"supports"},{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:33","stance":"supports"},{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:34","stance":"supports"},{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_record:35","stance":"supports"},{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:36","stance":"supports"},{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:37","stance":"supports"},{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:38","stance":"supports"},{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_record:39","stance":"supports"},{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:40","stance":"supports"},{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:41","stance":"supports"},{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:42","stance":"supports"},{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_record:43","stance":"supports"},{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:44","stance":"supports"},{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:45","stance":"supports"},{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:46","stance":"supports"},{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_record:47","stance":"supports"},{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:48","stance":"supports"},{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:49","stance":"supports"},{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:50","stance":"supports"}],"claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_record:30","alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:31","alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:32","alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:33","alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:34","alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_record:35","alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:36","alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:37","alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:38","alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_record:39","alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:40","alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:41","alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:42","alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_record:43","alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:44","alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:45","alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:46","alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_record:47","alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:48","alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:49","alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:50"]},{"evidence_id":"alpha:projection-evidence:827a22a1567eda11fa866650563f33918ee2975144378fa7fd6f46399da5427a","aliases":[],"source_type":"index_provider","source_family":"open_web","publisher":"Slickcharts S&P 500 constituent table (public observation, not S&P DJI license)","url":"https://www.slickcharts.com/sp500","title":"S&P 500","identifier":null,"locator":null,"source_date":null,"retrieved_at":"2026-09-02T01:46:54.035948+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"open_web","score":35,"source_family":"open_web","reasons":["Matched open_web source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:index_membership:51","stance":"supports"}],"claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:index_membership:51"]},{"evidence_id":"alpha:projection-evidence:24e3e0a1948ea10a66303a2e7032cc9bbc5c4edf5c6d4eb77b262a15ea2009a5","aliases":[],"source_type":"index_provider","source_family":"open_web","publisher":"Nasdaq official Nasdaq-100 list-type API","url":"https://api.nasdaq.com/api/quote/list-type/nasdaq100","title":"Nasdaq-100","identifier":null,"locator":null,"source_date":null,"retrieved_at":"2026-09-02T01:47:46.199772+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"open_web","score":35,"source_family":"open_web","reasons":["Matched open_web source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:index_membership:52","stance":"supports"}],"claim_ids":["alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:index_membership:52"]}]},"claims":[{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:legal_name:1","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"schema:legalName","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"VERTEX PHARMACEUTICALS INC / MA","claim_type":"legal_name","predicate_id":"alpha:predicate:legal_name","predicate_version":1,"machine_key":"legal_name","human_label":"Legal Name","governed_predicate":true,"machine_value":"VERTEX PHARMACEUTICALS INC / MA","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:3689ca642bfc033d173b2bc49bafdfee36e7db450c6b987dfdf226863ed0bae7","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma","source_date":null,"retrieved_at":"2026-10-16T13:51:24.289996+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:entity_status:3","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:entityStatus","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Public listing published","claim_type":"entity_status","predicate_id":"alpha:predicate:entity_status","predicate_version":1,"machine_key":"entity_status","human_label":"Entity Status","governed_predicate":true,"machine_value":"Public listing published","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:3689ca642bfc033d173b2bc49bafdfee36e7db450c6b987dfdf226863ed0bae7","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma","source_date":null,"retrieved_at":"2026-10-16T13:51:24.289996+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:official_website:4","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"schema:url","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"https://www.vrtx.com","claim_type":"official_website","predicate_id":"alpha:predicate:official_website","predicate_version":1,"machine_key":"official_website","human_label":"Official Website","governed_predicate":true,"machine_value":"https://www.vrtx.com","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:9015985fad92d88e74db5c67c27c419035e65a05002428d7db43c41165fb4d6f","identity_scope":"representation_reference","source_type":"SEC filing","title":"VERTEX PHARMACEUTICALS INC / MA Form 10-K (filed 2026-02-13)","publisher":"VERTEX PHARMACEUTICALS INC / MA Form 10-K (filed 2026-02-13)","url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000056/vrtx-20251231.htm","source_date":null,"retrieved_at":"2026-08-29T22:19:43Z","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:published_fact:5","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:country","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"US","claim_type":"published_fact","predicate_id":"alpha:predicate:published_fact","predicate_version":1,"machine_key":"published_fact","human_label":"Published Fact","governed_predicate":true,"machine_value":"US","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:3689ca642bfc033d173b2bc49bafdfee36e7db450c6b987dfdf226863ed0bae7","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma","source_date":null,"retrieved_at":"2026-10-16T13:51:24.289996+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:published_fact:6","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:jurisdiction","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"MA","claim_type":"published_fact","predicate_id":"alpha:predicate:published_fact","predicate_version":1,"machine_key":"published_fact","human_label":"Published Fact","governed_predicate":true,"machine_value":"MA","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:3689ca642bfc033d173b2bc49bafdfee36e7db450c6b987dfdf226863ed0bae7","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma","source_date":null,"retrieved_at":"2026-10-16T13:51:24.289996+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:published_fact:7","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:sector","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Healthcare","claim_type":"published_fact","predicate_id":"alpha:predicate:published_fact","predicate_version":1,"machine_key":"published_fact","human_label":"Published Fact","governed_predicate":true,"machine_value":"Healthcare","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:3689ca642bfc033d173b2bc49bafdfee36e7db450c6b987dfdf226863ed0bae7","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma","source_date":null,"retrieved_at":"2026-10-16T13:51:24.289996+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:published_fact:8","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:official_website","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"https://www.vrtx.com","claim_type":"published_fact","predicate_id":"alpha:predicate:published_fact","predicate_version":1,"machine_key":"published_fact","human_label":"Published Fact","governed_predicate":true,"machine_value":"https://www.vrtx.com","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:9015985fad92d88e74db5c67c27c419035e65a05002428d7db43c41165fb4d6f","identity_scope":"representation_reference","source_type":"SEC filing","title":"VERTEX PHARMACEUTICALS INC / MA Form 10-K (filed 2026-02-13)","publisher":"VERTEX PHARMACEUTICALS INC / MA Form 10-K (filed 2026-02-13)","url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000056/vrtx-20251231.htm","source_date":null,"retrieved_at":"2026-08-29T22:19:43Z","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:9","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jeffrey-m-leiden","object_label":"Jeffrey M. Leiden","object_source_name_forms":[],"value":"Jeffrey M. Leiden: Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jeffrey-m-leiden","name":"Jeffrey M. Leiden"},"title":"Chair","role_category":"director","committee":null,"is_board_chair":true,"is_independent":null,"start_date":"2009-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2009-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:document:4204b33890421295f8e7a46549171c478894d031cbbeaf34c4d37a139f430827","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:46.353365+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-03T00:00:00+00:00","effective_from":"2009-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:10","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:alan-garber","object_label":"Alan Garber","object_source_name_forms":[],"value":"Alan Garber: Director, CGNC; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:alan-garber","name":"Alan Garber"},"title":"Director","role_category":"director","committee":"CGNC; Nominating and Governance","is_board_chair":false,"is_independent":null,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:document:b9e93410980e0de555ceb4e5a4d7ad206b129a10d48051765eabd6aac39769cc","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:46.353365+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-03T00:00:00+00:00","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:11","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:bruce-sachs","object_label":"Bruce Sachs","object_source_name_forms":[],"value":"Bruce Sachs: Lead Independent Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:bruce-sachs","name":"Bruce Sachs"},"title":"Lead Independent Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"1998-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"1998-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:document:56bd4087aac2efb2a4f1ba7b4ec47c52e892e0a1f2b3f43408a98943c5b78b94","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:46.353365+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-03T00:00:00+00:00","effective_from":"1998-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:12","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:diana-mckenzie","object_label":"Diana McKenzie","object_source_name_forms":[],"value":"Diana McKenzie: Director, Audit; MDCC; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:diana-mckenzie","name":"Diana McKenzie"},"title":"Director","role_category":"director","committee":"Audit; MDCC; Compensation","is_board_chair":false,"is_independent":null,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:document:3a71ee491d4edd7ad4c444364a54a6cd98e460c73c0e4a530f213dc158d42163","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:44.05354+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-03T00:00:00+00:00","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:13","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jennifer-schneider","object_label":"Jennifer Schneider","object_source_name_forms":[],"value":"Jennifer Schneider: Director, MDCC; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jennifer-schneider","name":"Jennifer Schneider"},"title":"Director","role_category":"director","committee":"MDCC; Compensation","is_board_chair":false,"is_independent":null,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:document:f71d7ad63d317a89a9a896279a66a7b5677513bdc42b3aedecfff0ae33710b7f","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:44.446969+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-03T00:00:00+00:00","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:14","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:lloyd-carney","object_label":"Lloyd Carney","object_source_name_forms":[],"value":"Lloyd Carney: Director, Audit; CGNC; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:lloyd-carney","name":"Lloyd Carney"},"title":"Director","role_category":"director","committee":"Audit; CGNC; Nominating and Governance","is_board_chair":false,"is_independent":null,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:document:c0e47d7c4b33b030ce488922138a8c66f509c7255719adf92e5fa78fc8a4315a","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:46.353365+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-03T00:00:00+00:00","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:15","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:michel-lagarde","object_label":"Michel Lagarde","object_source_name_forms":[],"value":"Michel Lagarde: Director, Audit","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:michel-lagarde","name":"Michel Lagarde"},"title":"Director","role_category":"director","committee":"Audit","is_board_chair":false,"is_independent":null,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:document:4488043de931797e682a0536afc312cae15082e3f75b3d0b6fe366f5bb05bca4","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:44.446969+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-03T00:00:00+00:00","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:16","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:nancy-thornberry","object_label":"Nancy Thornberry","object_source_name_forms":[],"value":"Nancy Thornberry: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:nancy-thornberry","name":"Nancy Thornberry"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:document:3d9bdbb6429f64e8b2097690ef5c293918cb8bd125d855b9b9f14945d6186a6a","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:44.446969+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-03T00:00:00+00:00","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:17","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:reshma-kewalramani","object_label":"Reshma Kewalramani","object_source_name_forms":[],"value":"Reshma Kewalramani: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:reshma-kewalramani","name":"Reshma Kewalramani"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:document:40fbba593a76c37fecbd172eaa34cbf956f7086dc717081d95a2a6812f5f78ec","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:44.446969+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-03T00:00:00+00:00","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:18","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:sangeeta-bhatia","object_label":"Sangeeta Bhatia","object_source_name_forms":[],"value":"Sangeeta Bhatia: Director, CGNC; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:sangeeta-bhatia","name":"Sangeeta Bhatia"},"title":"Director","role_category":"director","committee":"CGNC; Nominating and Governance","is_board_chair":false,"is_independent":null,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:document:00cf7db9df23d437fa08d5fa748d02f566c1f00005ca782a52b7a6b0fd9dfa87","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:46.353365+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-03T00:00:00+00:00","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:19","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:suketu-upadhyay","object_label":"Suketu Upadhyay","object_source_name_forms":[],"value":"Suketu Upadhyay: Director, Audit; MDCC; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:suketu-upadhyay","name":"Suketu Upadhyay"},"title":"Director","role_category":"director","committee":"Audit; MDCC; Compensation","is_board_chair":false,"is_independent":null,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:document:65aa0f473458ddc2d4211d222c40e747b4e05982619bf8cfdbf0acff95ada785","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:44.446969+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-03T00:00:00+00:00","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:20","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:amit-k-sachdev-j-d","object_label":"Amit K. Sachdev, J.D.","object_source_name_forms":[],"value":"Amit K. Sachdev, J.D.: Executive Vice President, Chief Patient and External Affairs Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:amit-k-sachdev-j-d","name":"Amit K. Sachdev, J.D."},"title":"Executive Vice President, Chief Patient and External Affairs Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:document:643565076b28be530e27bc7c6bb3b8e5c4f9d2ef18b6ed3c3477341241fc6f2d","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRTX executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:15.745913+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-03","effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:21","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:charles-f-wagner-jr","object_label":"Charles F. Wagner, Jr.","object_source_name_forms":[],"value":"Charles F. Wagner, Jr.: Executive Vice President, Chief Operating and Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:charles-f-wagner-jr","name":"Charles F. Wagner, Jr."},"title":"Executive Vice President, Chief Operating and Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:document:10073b8c8eebe93a66db157b64687d2d3997bc19eb9044ee3696d363709c8ca8","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRTX executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:25.419065+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-03","effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:22","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:craig-b-thompson-m-d","object_label":"Craig B. Thompson, M.D.","object_source_name_forms":[],"value":"Craig B. Thompson, M.D.: Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:craig-b-thompson-m-d","name":"Craig B. Thompson, M.D."},"title":"Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:document:bcba2bd490d216b470f7f5bfee08ab970104433bf97d57f0ffbc8c0646e2f879","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRTX executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:15.433956+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-03","effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:23","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:duncan-j-mckechnie","object_label":"Duncan J. McKechnie","object_source_name_forms":[],"value":"Duncan J. McKechnie: Executive Vice President, Chief Commercial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:duncan-j-mckechnie","name":"Duncan J. McKechnie"},"title":"Executive Vice President, Chief Commercial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:document:ecb260e2fc826c6ce0d9dc519493846b3dad9f6e6755e4e91fe7588cfad341c0","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRTX executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:15.745913+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-03","effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:24","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:e-morrow-morrey-atkinson-iii-ph-d","object_label":"E. Morrow Morrey Atkinson, III, Ph.D.","object_source_name_forms":[],"value":"E. Morrow Morrey Atkinson, III, Ph.D.: Executive Vice President, Chief Technical Operations Officer, Head of Biopharmaceutical Science and Manufacturing Operations","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:e-morrow-morrey-atkinson-iii-ph-d","name":"E. Morrow Morrey Atkinson, III, Ph.D."},"title":"Executive Vice President, Chief Technical Operations Officer, Head of Biopharmaceutical Science and Manufacturing Operations","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:document:d6d906836dc60a9cb04c04a972bfe36d39683fb549b84171d05c66770d06294e","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRTX executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:15.433956+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-03","effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:25","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:jonathan-biller-j-d","object_label":"Jonathan Biller, J.D.","object_source_name_forms":[],"value":"Jonathan Biller, J.D.: Executive Vice President, Chief Legal Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:jonathan-biller-j-d","name":"Jonathan Biller, J.D."},"title":"Executive Vice President, Chief Legal Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:document:11c9716331af59ab69a0aebe420f77e14312aef120cdd656894afe2d18781f2b","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRTX executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:15.745913+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-03","effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:26","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:kristen-c-ambrose-cpa","object_label":"Kristen C. Ambrose, CPA","object_source_name_forms":[],"value":"Kristen C. Ambrose, CPA: Senior Vice President, Chief Accounting Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:kristen-c-ambrose-cpa","name":"Kristen C. Ambrose, CPA"},"title":"Senior Vice President, Chief Accounting Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:document:928c35a8eb10908bfafa795855984082d0cf83fa1beaab5098328b05eb4f4dbe","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRTX executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:15.433956+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-03","effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:27","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:mark-bunnage-d-phil","object_label":"Mark Bunnage, D.Phil","object_source_name_forms":[],"value":"Mark Bunnage, D.Phil: Executive Vice President, Chief Scientific Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:mark-bunnage-d-phil","name":"Mark Bunnage, D.Phil"},"title":"Executive Vice President, Chief Scientific Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:document:a12b804ccfa191b0a98a7bf01680ad0b850214b84d0467db3d7f4efedc2d6e5b","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRTX executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:15.745913+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-03","effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:28","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:ourania-nia-tatsis-ph-d","object_label":"Ourania Nia Tatsis, Ph.D.","object_source_name_forms":[],"value":"Ourania Nia Tatsis, Ph.D.: Executive Vice President, Chief Regulatory and Quality Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:ourania-nia-tatsis-ph-d","name":"Ourania Nia Tatsis, Ph.D."},"title":"Executive Vice President, Chief Regulatory and Quality Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:document:15a914491ac61cea12830ac4dae1f930b6ac324a037cb07cbd6c3f1bcb573247","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRTX executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:15.745913+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-03","effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:29","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:reshma-kewalramani-m-d","object_label":"Reshma Kewalramani, M.D.","object_source_name_forms":[],"value":"Reshma Kewalramani, M.D.: Chief Executive Officer and President","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:reshma-kewalramani-m-d","name":"Reshma Kewalramani, M.D."},"title":"Chief Executive Officer and President","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:document:bd8e625c43229cd60017e6c676a3355f568a031ad70b6019bbdfc8ac786e4c03","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRTX executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:25.419065+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-03","effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_record:30","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair not stated; Members Diana McKenzie; Lloyd Carney; Michel Lagarde; Suketu Upadhyay","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":null,"members":[{"display_name":"Diana McKenzie","person_slug":"diana-mckenzie","is_chair":false},{"display_name":"Lloyd Carney","person_slug":"lloyd-carney","is_chair":false},{"display_name":"Michel Lagarde","person_slug":"michel-lagarde","is_chair":false},{"display_name":"Suketu Upadhyay","person_slug":"suketu-upadhyay","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000153/vrtx-20260402.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:31","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:diana-mckenzie","object_label":"Diana McKenzie","object_source_name_forms":[],"value":"Diana McKenzie: member, Audit","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:diana-mckenzie","name":"Diana McKenzie"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000153/vrtx-20260402.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:32","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:lloyd-carney","object_label":"Lloyd Carney","object_source_name_forms":[],"value":"Lloyd Carney: member, Audit","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:lloyd-carney","name":"Lloyd Carney"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000153/vrtx-20260402.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:33","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:michel-lagarde","object_label":"Michel Lagarde","object_source_name_forms":[],"value":"Michel Lagarde: member, Audit","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:michel-lagarde","name":"Michel Lagarde"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000153/vrtx-20260402.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:34","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:suketu-upadhyay","object_label":"Suketu Upadhyay","object_source_name_forms":[],"value":"Suketu Upadhyay: member, Audit","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:suketu-upadhyay","name":"Suketu Upadhyay"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000153/vrtx-20260402.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_record:35","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"CGNC: Chair not stated; Members Alan Garber; Lloyd Carney; Sangeeta Bhatia","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"CGNC","canonical_type":"other","chair":null,"members":[{"display_name":"Alan Garber","person_slug":"alan-garber","is_chair":false},{"display_name":"Lloyd Carney","person_slug":"lloyd-carney","is_chair":false},{"display_name":"Sangeeta Bhatia","person_slug":"sangeeta-bhatia","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000153/vrtx-20260402.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:36","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:alan-garber","object_label":"Alan Garber","object_source_name_forms":[],"value":"Alan Garber: member, CGNC","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"CGNC","category":"other","role":"member","person":{"alpha_id":"alpha:person:alan-garber","name":"Alan Garber"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000153/vrtx-20260402.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:37","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:lloyd-carney","object_label":"Lloyd Carney","object_source_name_forms":[],"value":"Lloyd Carney: member, CGNC","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"CGNC","category":"other","role":"member","person":{"alpha_id":"alpha:person:lloyd-carney","name":"Lloyd Carney"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000153/vrtx-20260402.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:38","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:sangeeta-bhatia","object_label":"Sangeeta Bhatia","object_source_name_forms":[],"value":"Sangeeta Bhatia: member, CGNC","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"CGNC","category":"other","role":"member","person":{"alpha_id":"alpha:person:sangeeta-bhatia","name":"Sangeeta Bhatia"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000153/vrtx-20260402.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_record:39","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Compensation: Chair not stated; Members Diana McKenzie; Jennifer Schneider; Suketu Upadhyay","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Compensation","canonical_type":"compensation","chair":null,"members":[{"display_name":"Diana McKenzie","person_slug":"diana-mckenzie","is_chair":false},{"display_name":"Jennifer Schneider","person_slug":"jennifer-schneider","is_chair":false},{"display_name":"Suketu Upadhyay","person_slug":"suketu-upadhyay","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000153/vrtx-20260402.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:40","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:diana-mckenzie","object_label":"Diana McKenzie","object_source_name_forms":[],"value":"Diana McKenzie: member, Compensation","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:diana-mckenzie","name":"Diana McKenzie"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000153/vrtx-20260402.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:41","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:jennifer-schneider","object_label":"Jennifer Schneider","object_source_name_forms":[],"value":"Jennifer Schneider: member, Compensation","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:jennifer-schneider","name":"Jennifer Schneider"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000153/vrtx-20260402.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:42","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:suketu-upadhyay","object_label":"Suketu Upadhyay","object_source_name_forms":[],"value":"Suketu Upadhyay: member, Compensation","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:suketu-upadhyay","name":"Suketu Upadhyay"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000153/vrtx-20260402.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_record:43","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"MDCC: Chair not stated; Members Diana McKenzie; Jennifer Schneider; Suketu Upadhyay","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"MDCC","canonical_type":"other","chair":null,"members":[{"display_name":"Diana McKenzie","person_slug":"diana-mckenzie","is_chair":false},{"display_name":"Jennifer Schneider","person_slug":"jennifer-schneider","is_chair":false},{"display_name":"Suketu Upadhyay","person_slug":"suketu-upadhyay","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000153/vrtx-20260402.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:44","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:diana-mckenzie","object_label":"Diana McKenzie","object_source_name_forms":[],"value":"Diana McKenzie: member, MDCC","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"MDCC","category":"other","role":"member","person":{"alpha_id":"alpha:person:diana-mckenzie","name":"Diana McKenzie"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000153/vrtx-20260402.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:45","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:jennifer-schneider","object_label":"Jennifer Schneider","object_source_name_forms":[],"value":"Jennifer Schneider: member, MDCC","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"MDCC","category":"other","role":"member","person":{"alpha_id":"alpha:person:jennifer-schneider","name":"Jennifer Schneider"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000153/vrtx-20260402.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:46","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:suketu-upadhyay","object_label":"Suketu Upadhyay","object_source_name_forms":[],"value":"Suketu Upadhyay: member, MDCC","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"MDCC","category":"other","role":"member","person":{"alpha_id":"alpha:person:suketu-upadhyay","name":"Suketu Upadhyay"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000153/vrtx-20260402.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_record:47","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Nominating and Governance: Chair not stated; Members Alan Garber; Lloyd Carney; Sangeeta Bhatia","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Nominating and Governance","canonical_type":"nominating_governance","chair":null,"members":[{"display_name":"Alan Garber","person_slug":"alan-garber","is_chair":false},{"display_name":"Lloyd Carney","person_slug":"lloyd-carney","is_chair":false},{"display_name":"Sangeeta Bhatia","person_slug":"sangeeta-bhatia","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000153/vrtx-20260402.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:48","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:alan-garber","object_label":"Alan Garber","object_source_name_forms":[],"value":"Alan Garber: member, Nominating and Governance","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:alan-garber","name":"Alan Garber"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000153/vrtx-20260402.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:49","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:lloyd-carney","object_label":"Lloyd Carney","object_source_name_forms":[],"value":"Lloyd Carney: member, Nominating and Governance","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:lloyd-carney","name":"Lloyd Carney"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000153/vrtx-20260402.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:50","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:sangeeta-bhatia","object_label":"Sangeeta Bhatia","object_source_name_forms":[],"value":"Sangeeta Bhatia: member, Nominating and Governance","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:sangeeta-bhatia","name":"Sangeeta Bhatia"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000153/vrtx-20260402.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:index_membership:51","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasIndexMembership","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"S&P 500 (SPX)","claim_type":"index_membership","predicate_id":"alpha:predicate:index_membership","predicate_version":1,"machine_key":"index_membership","human_label":"Index Membership","governed_predicate":true,"machine_value":"S&P 500 (SPX)","corroboration_count":1,"source_claim_count":1,"valid_from":"2013-09-23","valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:827a22a1567eda11fa866650563f33918ee2975144378fa7fd6f46399da5427a","identity_scope":"representation_reference","source_type":"index_provider","title":"S&P 500","publisher":"Slickcharts S&P 500 constituent table (public observation, not S&P DJI license)","url":"https://www.slickcharts.com/sp500","source_date":null,"retrieved_at":"2026-09-02T01:46:54.035948+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":"2013-09-23","effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:index_membership:52","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasIndexMembership","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Nasdaq-100 (NDX)","claim_type":"index_membership","predicate_id":"alpha:predicate:index_membership","predicate_version":1,"machine_key":"index_membership","human_label":"Index Membership","governed_predicate":true,"machine_value":"Nasdaq-100 (NDX)","corroboration_count":1,"source_claim_count":1,"valid_from":"2026-09-01","valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:24e3e0a1948ea10a66303a2e7032cc9bbc5c4edf5c6d4eb77b262a15ea2009a5","identity_scope":"representation_reference","source_type":"index_provider","title":"Nasdaq-100","publisher":"Nasdaq official Nasdaq-100 list-type API","url":"https://api.nasdaq.com/api/quote/list-type/nasdaq100","source_date":null,"retrieved_at":"2026-09-02T01:47:46.199772+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":"2026-09-01","effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:security_listing:53","subject_id":"alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9","predicate":"alpha:hasSecurityListing","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"VRTX (NASDAQ)","claim_type":"security_listing","predicate_id":"alpha:predicate:security_listing","predicate_version":1,"machine_key":"security_listing","human_label":"Security Listing","governed_predicate":true,"machine_value":{"kind":"security_listing","ticker":"VRTX","exchange":"NASDAQ","exchange_display":"NASDAQ","mic":"XNAS","currency":"Unavailable","security_type":"equity","listing_status":"active","is_primary":true},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:24.289996+00:00","sources":[{"id":"alpha:projection-evidence:3689ca642bfc033d173b2bc49bafdfee36e7db450c6b987dfdf226863ed0bae7","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma","source_date":null,"retrieved_at":"2026-10-16T13:51:24.289996+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:3689ca642bfc033d173b2bc49bafdfee36e7db450c6b987dfdf226863ed0bae7","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma","source_date":null,"retrieved_at":"2026-10-16T13:51:24.289996+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:9015985fad92d88e74db5c67c27c419035e65a05002428d7db43c41165fb4d6f","identity_scope":"representation_reference","source_type":"SEC filing","title":"VERTEX PHARMACEUTICALS INC / MA Form 10-K (filed 2026-02-13)","publisher":"VERTEX PHARMACEUTICALS INC / MA Form 10-K (filed 2026-02-13)","url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000056/vrtx-20251231.htm","source_date":null,"retrieved_at":"2026-08-29T22:19:43Z","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:4204b33890421295f8e7a46549171c478894d031cbbeaf34c4d37a139f430827","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:46.353365+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:b9e93410980e0de555ceb4e5a4d7ad206b129a10d48051765eabd6aac39769cc","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:46.353365+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:56bd4087aac2efb2a4f1ba7b4ec47c52e892e0a1f2b3f43408a98943c5b78b94","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:46.353365+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:3a71ee491d4edd7ad4c444364a54a6cd98e460c73c0e4a530f213dc158d42163","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:44.05354+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:f71d7ad63d317a89a9a896279a66a7b5677513bdc42b3aedecfff0ae33710b7f","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:44.446969+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:c0e47d7c4b33b030ce488922138a8c66f509c7255719adf92e5fa78fc8a4315a","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:46.353365+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:4488043de931797e682a0536afc312cae15082e3f75b3d0b6fe366f5bb05bca4","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:44.446969+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:3d9bdbb6429f64e8b2097690ef5c293918cb8bd125d855b9b9f14945d6186a6a","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:44.446969+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:40fbba593a76c37fecbd172eaa34cbf956f7086dc717081d95a2a6812f5f78ec","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:44.446969+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:00cf7db9df23d437fa08d5fa748d02f566c1f00005ca782a52b7a6b0fd9dfa87","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:46.353365+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:65aa0f473458ddc2d4211d222c40e747b4e05982619bf8cfdbf0acff95ada785","identity_scope":"source_document_reference","source_type":"sec_filing","title":"Vertex Pharmaceuticals Incorporated director board source","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm","source_date":"2025-04-03T00:00:00+00:00","retrieved_at":"2026-05-03T01:47:44.446969+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:643565076b28be530e27bc7c6bb3b8e5c4f9d2ef18b6ed3c3477341241fc6f2d","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRTX executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:15.745913+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:10073b8c8eebe93a66db157b64687d2d3997bc19eb9044ee3696d363709c8ca8","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRTX executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:25.419065+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:bcba2bd490d216b470f7f5bfee08ab970104433bf97d57f0ffbc8c0646e2f879","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRTX executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:15.433956+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:ecb260e2fc826c6ce0d9dc519493846b3dad9f6e6755e4e91fe7588cfad341c0","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRTX executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:15.745913+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:d6d906836dc60a9cb04c04a972bfe36d39683fb549b84171d05c66770d06294e","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRTX executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:15.433956+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:11c9716331af59ab69a0aebe420f77e14312aef120cdd656894afe2d18781f2b","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRTX executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:15.745913+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:928c35a8eb10908bfafa795855984082d0cf83fa1beaab5098328b05eb4f4dbe","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRTX executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:15.433956+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:a12b804ccfa191b0a98a7bf01680ad0b850214b84d0467db3d7f4efedc2d6e5b","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRTX executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:15.745913+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:15a914491ac61cea12830ac4dae1f930b6ac324a037cb07cbd6c3f1bcb573247","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRTX executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:15.745913+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:bd8e625c43229cd60017e6c676a3355f568a031ad70b6019bbdfc8ac786e4c03","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRTX executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:25.419065+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000153/vrtx-20260402.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:827a22a1567eda11fa866650563f33918ee2975144378fa7fd6f46399da5427a","identity_scope":"representation_reference","source_type":"index_provider","title":"S&P 500","publisher":"Slickcharts S&P 500 constituent table (public observation, not S&P DJI license)","url":"https://www.slickcharts.com/sp500","source_date":null,"retrieved_at":"2026-09-02T01:46:54.035948+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:24e3e0a1948ea10a66303a2e7032cc9bbc5c4edf5c6d4eb77b262a15ea2009a5","identity_scope":"representation_reference","source_type":"index_provider","title":"Nasdaq-100","publisher":"Nasdaq official Nasdaq-100 list-type API","url":"https://api.nasdaq.com/api/quote/list-type/nasdaq100","source_date":null,"retrieved_at":"2026-09-02T01:47:46.199772+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.804,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.746,"cross_source_agreement":0.75,"temporal_completeness":0.333},"diagnostics":{"published_claims":52,"factual_claims":52,"claims_with_linked_evidence":52,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":39,"temporal_claims_with_valid_from":13,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-16T13:51:24.289996+00:00","observed_at":"2026-10-16T13:51:24.289996+00:00","reviewed_at":"2026-10-16T13:51:24.289996+00:00","verified_at":"2026-10-16T13:51:24.289996+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":52,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/vertex-pharmaceuticals-inc-ma/evidence","section":"evidence","href":"https://registry.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma?format=record&section=evidence","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}